Dalian BIO-CHEM Balance Sheet Health
Financial Health criteria checks 5/6
Dalian BIO-CHEM has a total shareholder equity of CN¥1.7B and total debt of CN¥155.0M, which brings its debt-to-equity ratio to 9.2%. Its total assets and total liabilities are CN¥2.0B and CN¥288.6M respectively. Dalian BIO-CHEM's EBIT is CN¥332.1M making its interest coverage ratio -16.4. It has cash and short-term investments of CN¥418.2M.
Key information
9.2%
Debt to equity ratio
CN¥155.04m
Debt
| Interest coverage ratio | -16.4x |
| Cash | CN¥418.18m |
| Equity | CN¥1.69b |
| Total liabilities | CN¥288.55m |
| Total assets | CN¥1.98b |
Recent financial health updates
Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly
Sep 26
These 4 Measures Indicate That Dalian BIO-CHEM (SHSE:603360) Is Using Debt Reasonably Well
Jun 12Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly
Mar 08Recent updates
Shareholders Are Optimistic That Dalian BIO-CHEM (SHSE:603360) Will Multiply In Value
Oct 29Market Might Still Lack Some Conviction On Dalian BIO-CHEM Company Limited (SHSE:603360) Even After 29% Share Price Boost
Oct 01Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly
Sep 26These 4 Measures Indicate That Dalian BIO-CHEM (SHSE:603360) Is Using Debt Reasonably Well
Jun 12Returns on Capital Paint A Bright Future For Dalian BIO-CHEM (SHSE:603360)
Apr 23Dalian BIO-CHEM Company Limited (SHSE:603360) Surges 41% Yet Its Low P/E Is No Reason For Excitement
Apr 01Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly
Mar 08Financial Position Analysis
Short Term Liabilities: 603360's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥260.8M).
Long Term Liabilities: 603360's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥27.8M).
Debt to Equity History and Analysis
Debt Level: 603360 has more cash than its total debt.
Reducing Debt: 603360's debt to equity ratio has increased from 3.1% to 9.2% over the past 5 years.
Debt Coverage: 603360's debt is well covered by operating cash flow (196.1%).
Interest Coverage: 603360 earns more interest than it pays, so coverage of interest payments is not a concern.